Anzeige
Mehr »
Dienstag, 18.11.2025 - Börsentäglich über 12.000 News
Skyharbour übernimmt 100% Russell Lake - Startschuss für die nächste Uran-Rally?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
73 Leser
Artikel bewerten:
(0)

PCORI Outlines a Patient-Centered Vision for Research and Methodology in JAMA Theme Issue on Comparative Effectiveness Research

WASHINGTON, April 17, 2012 /PRNewswire-USNewswire/ --Two articles in the April 18 issue of the Journal of the American Medical Association outline the Patient-Centered Outcomes Research Institute's vision for a new, methodologically rigorous focus on patients' needs in comparative effectiveness research (CER).

Such an approach, along with more actively engaging clinicians and other stakeholders in all aspects of the research process, can improve clinical decision-making and ultimately patient outcomes, PCORI Executive Director Joe V. Selby, MD, MPH, Chief Operating Officer Anne C. Beal, MD, MPH, and Lori Frank, PhD, now Director of Engagement Research at PCORI, write in a perspective in the special JAMA CER theme issue.

In a related Special Communication in the same JAMA issue, PCORI's 17-member Methodology Committee discusses the need for rigorous methodological standards and its role in ensuring that PCORI research produces high-integrity information.

PCORI "was named to emphasize the critical importance of a patient-centered perspective in conducting" CER, Drs. Selby, Beal and Frank write. PCORI's Board of Governors "determined early on that taking this name seriously, placing patients at the center of CER, and actively engaging clinicians and other stakeholders, was an ideal strategy to ensure that PCORI's research agenda stays focused on practical questions, relevant outcomes and study populations and the possibility that treatment effects may differ across patient populations," they add.

The authors also describe PCORI's process for establishing National Priorities for Research and a Research Agenda and what the drafts of those guiding documents, now being revised in response to public input, contain. The draft research agenda provides a preview of the broad-focused research PCORI likely is to support in its first round of primary funding announcements in late May.

In their Special Communication, Ethan Basch, MD, and colleagues from PCORI's Methodology Committee say patient-centered outcomes research (PCOR) "is distinguished from CER by its focus on patient-centeredness, determined by the extent to which patients' preferences, decision-making needs, and characteristics are addressed."

The Methodology Committee is developing standards for PCOR in four general areas: prioritizing research questions; using appropriate study designs; incorporating patient perspectives throughout the research continuum; and fostering efficient dissemination and implementation of results. The Methodology Committee's report will be delivered to PCORI's Board of Governors in early May, as required by the Patient Protection and Affordable Care Act, which authorized the establishment of the Institute.

JAMA is hosting a media briefing to unveil the theme issue at 10 a.m. ET today, April 17, 2012. PCORI is partnering with JAMA to provide a webcast of the event.

About PCORI
The Patient-Centered Outcomes Research Institute (PCORI) is an independent, non-profit organization authorized by Congress in 2010. Its mission is to fund research that will provide patients, their caregivers and clinicians with the evidence-based information needed to make better-informed health care decisions. PCORI is committed to continuously seeking input from a broad range of stakeholders to guide its work. More information is available at www.pcori.org.

SOURCE Patient-Centered Outcomes Research Institute

© 2012 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.